Patients with idiopathic pulmonary fibrosis who were given pirfenidone or nintedanib declined more slowly, researchers in two studies reported.
via NYT > Health http://ift.tt/1nbtm8z
via All Health and Fitness http://ift.tt/1sIrWnx
via Stay Fit and Healthy http://ift.tt/1lRPwgN
via May 21st 2011 wrong http://ift.tt/1hW77jx
No comments:
Post a Comment